Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | REGN | GSK | ||
| Company | Celgene Corp | Regeneron Pharmaceuticals | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 108.01 | 844.51 | 35.93 | ||
| High | 108.59 | 844.51 | 36.14 | ||
| Low | 107.27 | 813.53 | 35.63 | ||
| Last | 108.24 | 816.65 | 35.90 | ||
| Change | +0.11 | -12.78 | -1.12 | ||
| % Change | +0.10% | -1.54% | -3.03% | ||
| Volume | 191,230,496 | 879,500 | 14,281,600 | ||
| 20-Day Average Volume | 16,188,930 | 786,130 | 6,274,275 | ||
| Previous Close | 108.13 | 829.43 | 37.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 935.60 | 37.94 | ||
| 20-Day Raw Stochastic | 63.25% | 1.48% | 5.80% | ||
| 20-Day Relative Strength | 64.69% | 17.60% | 32.08% | ||
| Weighted Alpha | +46.30 | -11.86 | -5.29 | ||
| Today's Opinion | 100% Buy | 56% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | -11.50% since 10/30/24 | -3.00% since 10/30/24 | ||
| Low | 107.27 on 11/20/19 | 813.53 on 11/06/24 | 35.63 on 11/06/24 | ||
| High | 110.53 on 11/14/19 | 883.15 on 10/31/24 | 37.60 on 11/01/24 | ||
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | -19.37% since 10/04/24 | -7.52% since 10/04/24 | ||
| Low | 102.40 on 10/21/19 | 813.53 on 11/06/24 | 35.63 on 11/06/24 | ||
| High | 110.70 on 11/13/19 | 1,024.36 on 10/15/24 | 41.80 on 10/09/24 | ||
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | -23.40% since 08/06/24 | -7.19% since 08/06/24 | ||
| Low | 93.41 on 08/23/19 | 813.53 on 11/06/24 | 35.63 on 11/06/24 | ||
| High | 110.70 on 11/13/19 | 1,211.20 on 08/27/24 | 44.67 on 08/27/24 | ||
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | -14.81% since 05/06/24 | -17.38% since 05/06/24 | ||
| Low | 89.08 on 07/23/19 | 813.53 on 11/06/24 | 35.63 on 11/06/24 | ||
| High | 110.70 on 11/13/19 | 1,211.20 on 08/27/24 | 45.92 on 05/15/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 91,432,224 | 76,725,584 | ||
| Shares Outstanding, K | 711,714 | 110,235 | 2,072,544 | ||
| Annual Sales | 15,281,000,000 | 13,117,200,000 | 37,725,000,000 | ||
| Annual Net Income | 4,046,000,000 | 3,953,600,000 | 6,129,940,000 | ||
| Last Quarter Sales | 4,520,000,000 | 3,720,700,000 | 10,420,410,000 | ||
| Last Quarter Net Income | 1,691,000,000 | 1,340,600,000 | -75,430,000 | ||
| 60-Month Beta | 1.41 | 0.15 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | 12.46 on 10/31/24 | 1.27 on 10/30/24 | ||
| Latest Earnings Date | 10/31/19 | 10/31/24 | 10/30/24 | ||
| Most Recent Dividend | N/A | N/A | 0.385 on 08/16/24 | ||
| Next Ex-Dividends Date | N/A | N/A | 11/15/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 20.73 | 8.87 | ||